Immunomedix (US) presents early LeukoScan data:
This article was originally published in Clinica
Immunomedix (US) says its infectious disease diagnostic, LeukoScan, is at least as good as indium-111 white blood cell imaging, but much easier to perform. The data, presented on June 12th at the Society of Nuclear Medicine's annual meeting (Pines Bay, Florida), come from one of the 14 Phase III trial sites. Immunomedix is currently assessing clinical data on bone infection and diabetic foot ulcers. Phase IIIs on prosthesis infection and appendicitis are continuing.